Allergy News & Research | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Allergy

Three in 10 drug-related deaths in acute care due to omitted medicines, research reveals

Three in 10 drug-related deaths in acute care due to omitted medicines, research reveals

Accuracy in predicting patient outcomes in milk oral immunotherapy

Accuracy in predicting patient outcomes in milk oral immunotherapy

Towards a treatment for gluten intolerance

Towards a treatment for gluten intolerance

A hope for fish allergy sufferers?

A hope for fish allergy sufferers?

New drug could reduce risk of allergic reaction to peanuts in children and adolescents

New drug could reduce risk of allergic reaction to peanuts in children and adolescents

Results of landmark PALISADE trial published in New England Journal of Medicine

Results of landmark PALISADE trial published in New England Journal of Medicine

New EpiPen junior validation process mandated following ‘critical’ shortages in UK

New EpiPen junior validation process mandated following ‘critical’ shortages in UK

NICE issues draft guidance not recommending dupilumab

NICE issues draft guidance not recommending dupilumab

Omalizumab recommended in global chronic urticaria guideline

Omalizumab recommended in global chronic urticaria guideline

Peanut allergy drug passes clinical trial

Peanut allergy drug passes clinical trial

Guideline for the management of nut allergy helps to define diagnostic pathways, including the role of specific IgE testing

Reslizumab recommended by NICE

Reslizumab recommended by NICE

Marketing authorisation for dupilumab in moderate to severe atopic dermatitis recommended

Marketing authorisation for dupilumab in moderate to severe atopic dermatitis recommended

Candidate metabolomic network for bladder cancer diagnostics

Candidate metabolomic network for bladder cancer diagnostics

New guidance on diagnosis and management of allergic and non-allergic rhinitis published